相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 形态:
液态/粉状
- 保存条件:
-20℃保存
- 克隆性:
多克隆
- 标记物:
见说明书
- 适应物种:
人,大鼠,小鼠,兔
- 宿主:
Goat,Rabbit,Mouse
- 应用范围:
科研使用
- 浓度:
1mg/1ml
- 靶点:
来电咨询
- D2-40 Lymphatic Endothelial Marker Monoclonal Antibody, Purified (SIGNET)详细信息:
-
Description 
Purified Monoclonal Antibody against Lymphatic Endothelial Marker
(Formerly Signet Catalog Nos: 730-001, 730-01, 730-16 L1 Predilute, 730-26 L2 Predilute)Intended Use 
** In Vitro Diagnostic (IVD) ** Clone 
D2-40 Form 
Purified Antibody (in 0.01M PBS + 0.1% NaN3 + 1% BSA) Host 
Mouse Species Reactivity 
Human IsoType 
D2-40 Lymphatic Endothelial Marker Monoclonal Antibody, Purified (SIGNET)IgG1 Specificity 
Clone D2-40 reacts with a O-linked sialoglycoprotein (MW 40kDa) found on lymphatic endothelium, fetal testis and on the surface of testicular germ cell tumors. In recent studies clone D2-40 (D240) has shown staining in lymphatic channel endothelium but not in the adjacent capillary.
This antibody was developed using M2A.
Concentrated Format:
SIG-3730-100 [0.1 mL]
SIG-3730-1000 [1 mL]
Prediluted Formats:
SIG-3730-16 [6 mL]
SIG-3730-26 [6 mL]
Both are ready-to-use with either a Biotin-based (USA Ultra Streptavidin Detection, SIG-32250) or Biotin-free (ACUITYAdvanced Polymer Detection, SIG-32902) detection systems.Uses 
D2-40 Lymphatic Endothelial Marker Monoclonal Antibody, Purified (SIGNET)This antibody is effective in immunoblotting and immunohistochemistry (IHC). Suggested Working Dilution 
The optimal working dilution should be determined for each specific assay condition. - Western blot: 0.1 - 0.5 ug/mL
- IHC: ≥1:40 (concentrated format) for Biotin based detection systems such as USA Ultra Streptavidin Detection (SIG-32250).
Tissue Sections: Formalin-fixed, paraffin-embedded tissues, frozen sections
Pretreatment: Not required
Incubation: 60 minutes at room temperature
Storage 
Store between 2-8°C. References 
Choi WW, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF family gene expression. Mod Pathol 18:143-52, 2005.
Chu, AY, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105-110, 2005.
Dumoff KL, et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 18:97-104, 2005.
Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Ped Dev Pathol 8(2):181-9, 2005.
Fogt F, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 11:47-50, 2004.
Fogt F, et al. Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: A form fruste of lymphangiogenesis? Int J Molec Med 13:681-683, 2004.
Franchi A, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma.Cancer 101(5):973-978, 2004.
Franke FE, et al. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. J Cutan Pathol 31:362-367, 2004.
Giorgadze TA, et al. Lymphatic vessel density is significantly increased in melanoma. J Cutan Pathol 31:672-677, 2004.Warranty/Conditions 
Covance products may not be resold or modified for resale without prior written approval. - D2-40 Lymphatic Endothelial Marker Monoclonal Antibody, Purified (SIGNET)
- xy-1789R IL-12白介素12抗体
xy-1740R IL-4白介素4抗体
xy-6059R IGFBP9胰岛素样生长因子结合蛋白9抗体
xy-2710R IFNGR2干扰素-gamma受体2抗体
xy-2711R IL-27R白细胞介素27受体抗体
xy-2216R IL-1RA白介素-1受体拮抗剂抗体
xy-2898R IKK gammaKB抑制蛋白激酶γ抗体
xy-3227R phospho-IKK gamma (Ser85)磷酸化KB抑制蛋白激酶γ抗体
xy-3228R phospho-IKK gamma (Ser31)磷酸化KB抑制蛋白激酶γ抗体
xy-3229R Phospho-IKK alpha (Thr23)磷酸化KB抑制蛋白激酶α/IKK α 抗体
xy-3232R phospho-IKK beta(Tyr199)磷酸化KB抑制蛋白激酶β抗体
xy-3233R phospho-IKK beta(Tyr188)磷酸化KB抑制蛋白激酶β抗体
xy-3234R phospho-IKK alpha (Tyr463)磷酸化KB抑制蛋白激酶α抗体
xy-3230R phospho-IKK gamma (Ser376)磷酸化KB抑制蛋白激酶γ抗体
xy-3231R phospho-IKK beta(Ser466)磷酸化KB抑制蛋白激酶β抗体
xy-15552R IFI6干扰素alpha诱导蛋白6抗体
xy-2613R IL-17E/IL-25白介素-17E抗体
xy-2736R phospho-IRS-1(Ser307)磷酸化胰岛素受体底物p-IRS-1/2抗体
xy-15529R IARS2tRNA异亮氨酸连接酶抗体
xy-10132R Integrin alpha 2/CD49b整合素α2抗体
xy-15515R IFIT3干扰素诱导的三角形四肽重复蛋白3抗体
xy-15516R IFIT5干扰素诱导的三角形四肽重复蛋白5抗体
xy-15517R IFITM2干扰素诱导跨膜蛋白2抗体
xy-15518R IFITM5干扰素诱导跨膜蛋白5抗体
xy-15522R phospho-IFNAR1(Tyr466) 干扰素alpha/beta 受体1蛋白抗体
xy-15523R phospho-IFNGR1 (Tyr457)干扰素gamma受体1蛋白抗体
xy-15527R IF3EI 真核翻译起始因子3亚基L蛋白抗体
xy-15528R IFIT2干扰素诱导的三角形四肽重复蛋白2抗体
xy-15554R IFIT1B 干扰素诱导的三角形四肽重复蛋白1B抗体
xy-15530R IBP160160kDa内含子结合蛋白抗体
xy-15532R IBTKBruton酪氨酸激酶抑制剂蛋白抗体
xy-13591R IFI30γ干扰素诱导蛋白IP30抗体
xy-15546R IFFO中间丝家族孤啡肽1蛋白抗体
xy-12437R Inversin内脏器官发育转位相关蛋白NPH2抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
The production of monoclonal antibody by hybridoma
The production of monoclonal antibody by hybridoma fusion: Immortalization of sensitized B lymphocytes from immune mice. Overview
antibodies immunoreactive with ??smooth muscle actin. Similarly, lymphatic endothelial cells can be detected by antibodies immunoreactive to the hyaluronan receptor LYVE?1. Together, these approaches allow functional and morphological analysis of blood
技术资料暂无技术资料 索取技术资料




